Zhihui F. Liu
Hangzhou, 310000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Dendritic cell-derived exosomes from PDT-treated glioma cells enhance antitumor immunity as a subcellular vaccine.
Journal: Journal of translational medicine
Published: October 01, 2025
Turning attention to tumor-host interface and focus on the peritumoral heterogeneity of glioblastoma.
Journal: Nature communications
Published: February 28, 2024
Integration of Single-Cell and Bulk RNA-seq Data to Identify the Cancer-Associated Fibroblast Subtypes and Risk Model in Glioma.
Journal: Biochemical genetics
Published: November 22, 2023
COVPRIG robustly predicts the overall survival of IDH wild-type glioblastoma and highlights METTL1+ neural-progenitor-like tumor cell in driving unfavorable outcome.
Journal: Journal of translational medicine
Published: April 14, 2023
Using mixed reality technique combines multimodal imaging signatures to adjuvant glioma photodynamic therapy.
Journal: Frontiers in medicine
Published: February 22, 2023
Minimally invasive right infra-axillary thoracotomy for transaortic modified Morrow procedure: a series of 60 cases
Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]
Published: January 18, 2023
Expression of intra-tumoral necrosis-associated cytokine pattern correlated with prognosis and immune status in glioma.
Journal: Frontiers in molecular neuroscience
Published: December 06, 2022
Stromal protein CCN family contributes to the poor prognosis in lower-grade gioma by modulating immunity, matrix, stemness, and metabolism.
Journal: Frontiers in molecular biosciences
Published: August 24, 2022
Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas.
Journal: Frontiers in oncology
Published: June 24, 2022
Integrated genomic, transcriptomic, and epigenetic analyses identify a leukotriene synthesis-related M2 macrophage gene signature that predicts prognosis and treatment vulnerability in gliomas.
Journal: Frontiers in immunology
Published: June 16, 2022
A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma.
Journal: Frontiers in molecular biosciences
Published: June 11, 2022
IGFBPs were associated with stemness, inflammation, extracellular matrix remodeling and poor prognosis of low-grade glioma.
Journal: Frontiers in endocrinology
Published: May 13, 2022
Last Updated: 09/26/2026